Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Regeneron Pharmaceuticals
Pharma
Sanofi is going all in on Dupixent's next potential nod in COPD
Ahead of an FDA action date this summer, Sanofi is prepping for Dupixent's potential debut in its next "major growth pillar," CEO Paul Hudson said.
Fraiser Kansteiner
Apr 25, 2024 12:37pm
Roche's juggernaut Vabysmo routs analyst consensus
Apr 24, 2024 11:29am
DOJ sues Regeneron for under-reporting Eylea price to Medicare
Apr 11, 2024 11:12am
Ad astra: Regeneron launches stargazing-themed Eylea HD campaign
Mar 20, 2024 10:46am
Appeals court backs Regeneron's antitrust suit against Novartis
Mar 19, 2024 10:40am
FDA speeds Sanofi, Regeneron's application for Dupixent in COPD
Feb 22, 2024 11:25pm